Showing results (2001-2010 of 2,860) with videos related to

Sort By:
Pageof 286
Neuropsychobiology|February 9, 2008
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetineGeorge I Papakostas, Christine M Crawford, Margaret J Scalia, et al.
Neuropsychobiology|January 1, 1977
Theoretical and therapeutic potential of indolamine precursors in affective disordersA Wirz-Justice
Neuropsychobiology|January 1, 1987
Effects of fenfluramine on EEG and brainstem average evoked response in infantile autism. Preliminary investigationN Raz, W S Pritchard, G J August
Neuropsychobiology|January 1, 1987
Viloxazine as a betamimetic antidepressant drugM Bourin, A Ortega, C Larousse
Neuropsychobiology|January 1, 1987
Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex?S Pellow, S E File
Neuropsychobiology|April 1, 2019
Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient CohortsIlona Gorbovskaya, Sarah Kanji, Jonathan C W Liu, et al.
Neuropsychobiology|July 25, 2019
Brain Structure and Subclinical Symptoms: A Dimensional Perspective of Psychopathology in the Depression and Anxiety SpectrumBianca Besteher, Christian Gaser, Igor Nenadić
Neuropsychobiology|April 4, 2019
Moderator Effects of Life Stress on the Association between MAOA-uVNTR, Depression, and BurnoutThomas Plieger, Martin Melchers, Andrea Felten, et al.
Neuropsychobiology|April 5, 2019
Reduced Sensitivity to Non-Fear-Related Stimulus Changes in Panic DisorderJohannes Rentzsch, Lars Thoma, Katharina Gaudlitz, et al.
Neuropsychobiology|April 5, 2019
A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia SymptomsQin Xiang Ng, Alex Yu Sen Soh, Nandini Venkatanarayanan, et al.
Pageof 286